NASDAQ: NHIVNewhold Investment Corp IV Stock
$10.10+0.00 (+0%)
Updated Jul 31, 2026
NHIV Price
$10.10
Fair Value Price
N/A
Market Cap
$277.49M
52 Week Low
$9.80
52 Week High
$11.50
P/E
N/A
P/B
-4,624.89x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-5.68
Operating Cash Flow
N/A
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NHIV Overview
SPAC incorporated in 2025. Completed IPO in April 2026, raising $175 million. Targets industrial technology companies in the transportation, distribution, manufacturing, and robotics industries with aggregate enterprise value of $700 million or greater. Has a 24-month window from April 16, 2026 to complete a business combination.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NHIV's potential to beat the market
- NHIV doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
NHIV
RankedUnranked of 35
RankedUnranked of 35
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.85 | C | |
| $10.21 | C | |
| $11.29 | C |
Be the first to know about important NHIV news, forecast changes, insider trades & much more!
NHIV News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NHIV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NHIV's debt relative to shareholder equity (-5.68) is still negative, so we do not consider if debt has reduced over the past 5 years
Shrinking Debt Financials
NHIV's debt to equity ratio (-5.68) is negative, which is a more serious situation than a high ratio
Healthy Debt to Equity Financials
Insufficient data to perform Discounted... subscribe to Premium to read more.
Below Fair Value Valuation
There are 30 more NHIV due diligence checks available for Premium users.
Valuation
NHIV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-4,624.89x
Industry
50.46x
NHIV's financial health
Profit margin
Revenue
$0.0
Net Income
-$38.0k
Profit Margin
0%
Assets to liabilities
Assets
$281.0k
Liabilities
$341.0k
Debt to equity
-5.68
NHIV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NHIV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$0.0
Investing
$0.0
Financing
$0.0
NHIV vs Shell Company Stocks
Newhold Investment IV Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.